As of March 2024 Global Cord Blood has a market cap of $0.18 Billion. This makes Global Cord Blood the world's 7045th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.18 B | 10.66% |
2023 | $0.16 B | -59.16% |
2022 | $0.40 B | -21.44% |
2021 | $0.50 B | 12.94% |
2020 | $0.45 B | -25.8% |
2019 | $0.60 B | -22.48% |
2018 | $0.78 B | -30.59% |
2017 | $1.12 B | 152.82% |
2016 | $0.44 B | -3.92% |
2015 | $0.46 B | 40.93% |
2014 | $0.32 B | 12.72% |
2013 | $0.29 B | 53.64% |
2012 | $0.19 B | -2.36% |
2011 | $0.19 B | -35.62% |
2010 | $0.30 B | -29.54% |
2009 | $0.43 B | 1017.37% |
2008 | $38.5 M | -1.26% |
2007 | $38.99 M |
On Mar 28th, 2024 the market cap of Global Cord Blood was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
RadNet RDNT | $3.58 B | 1,883.92% | ๐บ๐ธ USA |
National Healthcare
NHC | $1.45 B | 702.46% | ๐บ๐ธ USA |
NeoGenomics
NEO | $2.00 B | 1,009.62% | ๐บ๐ธ USA |
Cryo-Cell CCEL | $61.81 M | -65.81% | ๐บ๐ธ USA |